Glucose Variability and Coronary Artery Disease

Area of Science:

• Endocrinology
• Cardiology
• Metabolic Syndrome

Background:

• Traditional diabetes indicators include fasting blood glucose, postprandial blood glucose, and glycated haemoglobin.
• Emerging evidence suggests glucose variability poses greater risks to coronary arteries than sustained hyperglycemia.
• Coronary artery disease (CAD) remains a leading cause of mortality worldwide.

Purpose of the Study:

• To summarize recent findings on glucose variability and its association with coronary artery disease.
• To explore glucose variability as a potential marker for CAD progression and plaque vulnerability.
• To discuss glucose variability as a novel therapeutic target for secondary CAD prevention.

Main Methods:

• Literature review of recent studies on glucose variability and cardiovascular health.
• Analysis of evidence linking glucose fluctuations to coronary artery damage.
• Synthesis of current understanding of glucose variability's role in CAD pathogenesis.

Main Results:

• Glucose variability is increasingly recognized as detrimental to coronary artery health.
• Elevated glucose variability correlates with increased CAD progression and plaque instability.
• Glucose variability may serve as an independent risk factor for adverse cardiovascular events.

Conclusions:

• Glucose variability is a critical factor in coronary artery disease development and progression.
• Targeting glucose variability could offer a new strategy for secondary prevention in CAD patients.
• Future research should prioritize early detection and management of glucose variability to improve patient outcomes.